SIM
NYMX

Sonora Investment Management’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Sonora Investment Management’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,800
Closed -$6K – 1130
2021
Q2 		$6K Buy
+3,800
New +$7.04K ﹤0.01% 795

Other funds holding NYMX

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
WB
Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Sonora Investment Management's NYMX Position: Q3 2021 in Review

Sonora Investment Management sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2021, closing a stake of 3,800 shares — an estimated $6K sold.

Sonora Investment Management first reported a position in NYMX in Q2 2021 and held it in 1 quarter. The position peaked at $6K in Q2 2021. 38 funds tracked by Wall St. Rank hold NYMX as of Q3 2021.

  • Sonora Investment Management reported no remaining Nymox Pharmaceutical Corp position as of Q3 2021 after selling out during the quarter.
  • Sonora Investment Management sold 3,800 Nymox Pharmaceutical Corp shares in Q3 2021, an estimated $6K.
  • Sonora Investment Management first reported a position in Nymox Pharmaceutical Corp in Q2 2021 and held it in 1 quarter.
  • Sonora Investment Management's Nymox Pharmaceutical Corp position peaked at $6K in Q2 2021.
  • 38 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.